---
title: "AksharChem (India) Ltd (AKSHARCHEM) — Share Price, Financials & Analysis"
symbol: "AKSHARCHEM"
company: "AksharChem (India) Ltd"
canonical: "https://tapetide.com/stocks/AKSHARCHEM"
isin: "INE542B01011"
nse_symbol: "AKSHARCHEM"
bse_code: "524598"
sector: "Chemicals"
industry: "Dyes & Pigments"
market_cap_cr: 311.76
generated_at: "2026-09-13T19:17:28.389Z"
---

# AksharChem (India) Ltd (AKSHARCHEM)

Canonical page: https://tapetide.com/stocks/AKSHARCHEM

## Company

- **NSE Symbol:** AKSHARCHEM
- **BSE Code:** 524598
- **ISIN:** INE542B01011
- **Sector:** Chemicals
- **Industry:** Dyes & Pigments
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2002-02-14
- **CEO:** Ms. Paru Mrugesh Jaykrishna B.A., LL.B., M.A.
- **Employees:** 168
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aksharchemindia.com

## About

Incorporated in 1989, Aksharchem (India) Ltd manufactures & exports Dyes Pigments and Precipitated Silica[1]

## Latest Price

- **Price:** ₹423.4
- **Change:** +14.95 (+3.66%)
- **Open:** ₹390
- **Day High:** ₹428.85
- **Day Low:** ₹388.05
- **Previous Close:** ₹408.45
- **Volume:** 18217
- **As Of:** 2026-09-11T09:58:58+00:00

## Key Fundamentals

Observed at 2026-09-11T04:50:19.842341Z.

- **Market Cap:** ₹311.76 Cr
- **Classification:** Microcap
- **P/E (reported):** 23.4
- **P/E (TTM):** 24.19
- **EPS (TTM):** ₹17.5
- **Book Value:** ₹325.57
- **Price to Book:** 1.26
- **Dividend Yield:** 0.12%
- **ROE:** 19.57%
- **ROCE:** 29.32%
- **Debt to Equity:** 0.41
- **Revenue (yearly):** ₹189 Cr
- **Net Income:** ₹16.6 Cr
- **EBITDA:** ₹33.5 Cr
- **52-Week High:** ₹472
- **52-Week Low:** ₹141.3
- **RSI (14):** 64.82

## Tapetide Score

- **Score:** 50 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 47.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 56.12 | 9% |
| growth | 58.13 | 9% |
| momentum | 98.9 | 12% |
| ownership | 50 | 24% |
| quality | 41.54 | 22% |
| valuation | 45.03 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- The company has delivered a poor sales growth of 8.61% over past five years.
- Company has a low return on equity of -2.03% over last 3 years.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -52.82% | 896.57% | 394.52% |
| ebitda margin growth | 102.47% | 21.36% | — | — |
| net income growth | 135% | 3.75% | — | — |
| revenue growth | 22.27% | -6.48% | 4% | 9% |
| roce | 117.4% | -10.39% | — | — |
| roe | 134.49% | -12.59% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 73 | 75 | 82 | 86 | 79 | 91 | 91 | 97 | 89 | 80 | 106 | 141 |
| Expenses | 76 | 70 | 81 | 80 | 73 | 84 | 84 | 91 | 87 | 77 | 100 | 118 |
| Operating Profit | -3 | 5 | 0 | 6 | 6 | 6 | 6 | 6 | 2 | 3 | 5 | 23 |
| OPM % | -4.4 | 7 | 0.5 | 7 | 8 | 7 | 7 | 7 | 2.6 | 3.6 | 5 | 16 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | -8 | 1 | -4 | 2 | 1 | 2 | 1 | 1 | -1 | -3 | -1 | 16 |
| Tax % | 1 | 57 | 50 | 28 | 26 | 22 | -7 | 31 | -3 | 50 | -584 | 5 |
| Net Profit | -8 | 0 | -6 | 1 | 1 | 1 | 1 | 1 | -1 | -5 | 5 | 15 |
| EPS in Rs | -9.46 | 0.41 | -7.49 | 1.43 | 1.29 | 1.48 | 1.73 | 0.88 | -1.71 | -5.75 | 6.03 | 18.93 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 264 | 323 | 260 | 246 | 380 | 335 | 302 | 346 | 372 | 416 |
| Expenses | 223 | 288 | 234 | 223 | 349 | 319 | 301 | 321 | 355 | 383 |
| Operating Profit | 42 | 34 | 26 | 24 | 32 | 15 | 2 | 25 | 17 | 33 |
| OPM % | 16 | 11 | 10 | 10 | 8 | 4.6 | 0.5 | 7 | 4.6 | 8 |
| Other Income | 7 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 7 | 8 |
| Depreciation | 5 | 6 | 7 | 7 | 12 | 13 | 14 | 14 | 17 | 17 |
| Profit before tax | 43 | 33 | 19 | 17 | 18 | 0 | -16 | 6 | -4 | 10 |
| Tax % | 28 | 32 | 18 | 28 | 11 | 88 | 20 | 18 | -90 | — |
| Net Profit | 31 | 23 | 16 | 12 | 16 | -1 | -19 | 5 | 0 | 14 |
| EPS in Rs | 37.26 | 27.54 | 19.16 | 15.24 | 19.81 | -1.17 | -23.25 | 5.94 | -0.55 | 17.5 |
| Dividend Payout % | 9 | 13 | 18 | 23 | 3 | -43 | -2 | 8 | -91 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 133 | 230 | 249 | 257 | 271 | 272 | 270 | 251 | 256 | 254 |
| Borrowings | 32 | 0 | 12 | 13 | 15 | 50 | 25 | 52 | 67 | 108 |
| Other Liabilities | 47 | 61 | 47 | 45 | 62 | 76 | 62 | 70 | 85 | 82 |
| Total Liabilities | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 452 |
| Fixed Assets | 65 | 86 | 126 | 128 | 229 | 231 | 225 | 235 | 232 | 287 |
| CWIP | 9 | 26 | 31 | 62 | 6 | 16 | 17 | 11 | 45 | 8 |
| Investments | 51 | 77 | 21 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 94 | 110 | 138 | 131 | 120 | 159 | 122 | 135 | 139 | 156 |
| Total Assets | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 452 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 41 | 30 | -9 | 26 | 49 | 4 | 38 | -7 | 35 | 2 |
| Cash from Investing Activity | -32 | -63 | -2 | -20 | -49 | -24 | -8 | -16 | -44 | -36 |
| Cash from Financing Activity | -5 | 33 | 7 | -7 | 1 | 18 | -30 | 23 | 9 | 34 |
| Net Cash Flow | 3 | 0 | -4 | 0 | 1 | -1 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 26 | -14 | -60 | -14 | -2 | -20 | 29 | -23 | -9 | -34 |
| CFO/OP | 80 | 102 | 1 | 116 | 211 | 27 | 255 | -759 | 141 | 11 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 20 | 38 | 43 | 42 | 42 | 51 | 39 | 57 | 43 | 61 |
| Inventory Days | 102 | 68 | 65 | 104 | 148 | 115 | 99 | 131 | 130 | 119 |
| Days Payable | 100 | 70 | 49 | 62 | 97 | 80 | 64 | 88 | 106 | 88 |
| Cash Conversion Cycle | 22 | 35 | 59 | 83 | 93 | 86 | 75 | 100 | 67 | 92 |
| Working Capital Days | 31 | 56 | 85 | 104 | 75 | 62 | 69 | 55 | 18 | -4 |
| ROCE % | 53 | 21 | 13 | 7 | 6 | 6 | 1 | -4 | 3 | 0 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% |
| FIIs | 0.68% | 0% | 0.43% | 0.39% | 0.07% | 0% | 0% | 0.03% | 0.02% | 0% | 0% | 0% |
| DIIs | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 28.16% | 27.94% | 28.6% | 28.66% | 28.86% | 28.83% | 28.69% | 28.7% | 28.25% | 27.11% | 27.44% | 27.18% |
| Others | 8.41% | 9.31% | 8.22% | 8.2% | 8.32% | 8.41% | 8.55% | 8.51% | 8.98% | 10.14% | 9.81% | 10.07% |
| No. of Shareholders | 15506 | 15267 | 15119 | 14629 | 13740 | 13602 | 13426 | 13475 | 13139 | 12060 | 11843 | 11715 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 14 / 5 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 420.18 | Buy |
| EMA (10) | 412.74 | Buy |
| SMA (20) | 371.4 | Buy |
| EMA (20) | 380.57 | Buy |
| SMA (50) | 299.36 | Buy |
| EMA (50) | 321.32 | Buy |
| SMA (100) | 255.87 | Buy |
| EMA (100) | 280.28 | Buy |
| SMA (200) | 236.98 | Buy |
| EMA (200) | 256.11 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 67.63 | Neutral |
| MACD (12,26,9) | 41.52 | Buy |
| Stochastic (14,3,3) | 68.52 | Neutral |
| ADX (14) | 48.72 | Buy |
| Williams %R (14) | -32.44 | Neutral |
| ATR (14) | 21.69 | High Volatility |
| ROC (12) | 20.91 | Buy |
| Stoch RSI (14) | 10.85 | Buy |
| UO (7,14,28) | 67.53 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df82f62f-2dfb-473d-824e-c9f1b8975037.pdf) |
| 2026-08-29 | [Notice Of 37Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99e6070d-b750-4d69-92f2-aa01504a5c8a.pdf) |
| 2026-08-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a390b860-fa53-4dfd-a7d1-74877258def8.pdf) |
| 2026-08-29 | [Intimation Of Record Date](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4c071de-a51a-4e6f-bcb5-9c029aafca99.pdf) |
| 2026-08-29 | [Letter To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34b9eea9-e09a-4929-b3d4-26cd3fdac2ab.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afb91a40-2b15-4441-8f24-11e09fdb9486.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d23ff7c-bbd7-410f-b518-d6b3947301fd.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20c2b354-d701-4a81-aa65-0a55838cfc93.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0234fcf-502d-4dfd-af65-3dcdf09b7877.pdf) |
| 2026-07-06 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea35ec44-653a-4ecb-9568-a845756f462e.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e4018a0-d77d-4ff5-8b15-24d21161c594.pdf) |
| 2026-05-21 | [Audited Financial Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b060529-a793-4e40-a00f-c02ae4e847b6.pdf) |
| 2026-01-28 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e4e66cf-6469-4f10-ab52-434e9be5bd7f.pdf) |
| 2025-11-12 | [Unaudited Financial Result For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36f02186-3171-48cd-864b-cba41b0f4440.pdf) |
| 2025-07-25 | [Unaudited Financial Result June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=194138a3-a9aa-4d85-8113-cf3a905da2a6.pdf) |
| 2025-05-21 | [Audited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=710ad59b-246a-4913-a811-771ebee1d55a.pdf) |
| 2025-02-10 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8554f9a0-71a2-4746-b142-828655075a02.pdf) |
| 2024-11-12 | [Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e68a633-fc1b-4716-a9e7-c151a36d1f4b.pdf) |
| 2024-08-02 | [Unaudited Financial Results For The Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe2e0743-7324-403a-8aad-bd84df74e0ad.pdf) |
| 2024-05-29 | [Audited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3203973-3df8-4c0e-9f36-1a2f7775f8b7.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - AksharChem says it is not a Large Corporate under SEBI debt framework; borrowing was Rs 27.96 crore on 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 9 Apr - AksharChem says it is not a Large Corporate under SEBI debt framework; borrowing was Rs 27.96 crore on 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73bb221c-f975-480e-bb0c-7812f798bad0.pdf) |
| 8 Jan - The securities received from the depository participants for dematerialisation during the quarter ended 31st December 2025, were confirmed(accepted/rejected) to the depositories by us and that … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jan - The securities received from the depository participants for dematerialisation during the quarter ended 31st December 2025, were confirmed(accepted/rejected) to the depositories by us and that …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88e63bb2-99b5-4500-aa3d-9a76a3bee4d8.pdf) |
| 6 Feb - CARE (Feb 6, 2026) reaffirmed Aksharchem ratings; LT ₹28.41Cr, LT/ST ₹80Cr, ST ₹15Cr; outlook revised to Negative | [Announcement under Regulation 30 (LODR)-Credit Rating 6 Feb - CARE (Feb 6, 2026) reaffirmed Aksharchem ratings; LT ₹28.41Cr, LT/ST ₹80Cr, ST ₹15Cr; outlook revised to Negative](https://www.bseindia.com/xml-data/corpfiling/AttachHis/467a68e5-4556-4cd5-9de5-8aa8519cad58.pdf) |
| 26 Mar - Trading window closed April 1, 2026 until 48 hours after audited FY2025-26 results. | [Closure of Trading Window 26 Mar - Trading window closed April 1, 2026 until 48 hours after audited FY2025-26 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9dc2c94b-56dd-4499-8593-87a685c89efb.pdf) |
| 26 Feb - CARE reaffirms Aksharchem LT A- for ₹28.41cr and LT/ST ₹80cr; assigns ST A2+ for ₹20cr; outlook Negative 26 Feb 2026 | [Announcement under Regulation 30 (LODR)-Credit Rating 26 Feb - CARE reaffirms Aksharchem LT A- for ₹28.41cr and LT/ST ₹80cr; assigns ST A2+ for ₹20cr; outlook Negative 26 Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e8036754-9235-4d95-8b05-58165a6c8b03.pdf) |
| 2 Feb - Board meeting on 12 Feb 2026 to approve Q3/9M (Dec 31, 2025) unaudited results; trading window closed. | [Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 To Consider Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2025. 2 Feb - Board meeting on 12 Feb 2026 to approve Q3/9M (Dec 31, 2025) unaudited results; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02bb7c4b-eb9b-40b1-b760-2c3326c6b62e.pdf) |
| 19 Mar - H-Acid plant at Indrad resumed production effective 19 Mar 2026 after planned maintenance; no material financial impact. | [Announcement Under Regulation 30 (LODR) 19 Mar - H-Acid plant at Indrad resumed production effective 19 Mar 2026 after planned maintenance; no material financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/63f14d3d-34ee-4222-a0d4-eb799738388f.pdf) |
| 16 Feb - In Compliance with Regulation 47 of SEBI(LODR) Regulation,2015, we are enclosing herewith the copy of newspaper publication of Un-audited Financial Results for quarter and nine … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb - In Compliance with Regulation 47 of SEBI(LODR) Regulation,2015, we are enclosing herewith the copy of newspaper publication of Un-audited Financial Results for quarter and nine …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5508d1aa-a7f6-46e3-af71-155120271185.pdf) |
| 16 Feb - H-Acid plant at Indrad shut from Feb 16, 2026 for repair/maintenance, expected 3-4 weeks. | [Announcement Under Regulation 30 (LODR) 16 Feb - H-Acid plant at Indrad shut from Feb 16, 2026 for repair/maintenance, expected 3-4 weeks.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d59d29ef-870b-4857-98aa-d0b253324f1e.pdf) |
| 12 Feb - Approved unaudited results for quarter/nine months ended 31 Dec 2025; unmodified limited review; GM reappointed Apr 22, 2026–Apr 21, 2027. | [Board Meeting Outcome for Outcome Of The Board Meeting As Per Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 12 Feb - Approved unaudited results for quarter/nine months ended 31 Dec 2025; unmodified limited review; GM reappointed Apr 22, 2026–Apr 21, 2027.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9f39ce73-5a16-43b3-80ee-18ae9b2a7092.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/94304f2f-15a5-420d-829e-82df30478383.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e64ed0fc-93a2-4670-82e4-e7140fda64a6.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34c390ae-6b48-4b04-bd8d-61b506dff2e7.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dcbf03bf-f533-4546-8492-ca841bac984c.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e803231d-d131-40b0-b11d-1d9527f55cd0.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b5a77b88-1da6-41af-99ff-65554db81d49.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524598/76258524598.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/504180/74170504180.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524598/71354524598.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/504180/69228504180.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Jan 2017 | [Concall - Jan 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2627333F_0D85_47B1_BEAB_52BC9C24209F_181201.pdf) |
| Dec 2016 | [Concall - Dec 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=FB8A0B63_06CD_4266_B6FF_CE88D7E94ED3_142457.pdf) |
| Dec 2016 | [Concall - Dec 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F89F0532_E098_4A04_92DF_C989541839DB_153949.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:17:28.389Z.